Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.

× No keyword cloud information.

12 in total

Review 1. Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease.

Authors: Antonio Di Sabatino; Lucio Liberato; Monia Marchetti; Paolo Biancheri; Gino R Corazza
Journal: Intern Emerg Med Date: 2011-10 Impact factor: 3.397

Review 2. Economic implications of biological therapies for Crohn's disease: review of infliximab.

Authors: Keith Bodger
Journal: Pharmacoeconomics Date: 2005 Impact factor: 4.981

3. Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

Authors: Steven J Edwards; Samantha Barton; Mariana Bacelar; Charlotta Karner; Peter Cain; Victoria Wakefield; Gemma Marceniuk
Journal: Health Technol Assess Date: 2021-03 Impact factor: 4.014

Review 4. The pharmacoeconomics of biologic therapy for IBD.

Authors: Russell D Cohen
Journal: Nat Rev Gastroenterol Hepatol Date: 2010-02 Impact factor: 46.802

5. Demonstrating the value of biologics: a call to action.

Authors: Jeff Clough
Journal: Biotechnol Healthc Date: 2007-08

Review 6. Crohn's disease.

Authors: Sarah C Mills; Alexander C von Roon; Paris P Tekkis; Timothy R Orchard
Journal: BMJ Clin Evid Date: 2011-04-27

Review 7. The chronic gastrointestinal consequences associated with campylobacter.

Authors: Mark S Riddle; Ramiro L Gutierrez; Elena F Verdu; Chad K Porter
Journal: Curr Gastroenterol Rep Date: 2012-10

Review 8. Cost effectiveness of treatments for inflammatory bowel disease.

Authors: Keith Bodger
Journal: Pharmacoeconomics Date: 2011-05 Impact factor: 4.558

9. The economic burden of TNFα inhibitors and other biologic treatments in Norway.

Authors: Jan Norum; Wenche Koldingsnes; Torfinn Aanes; Margaret Aarag Antonsen; Jon Florholmen; Masahide Kondo
Journal: Clinicoecon Outcomes Res Date: 2011-03-21

10. Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe.

Authors: Petra Baji; László Gulácsi; Valentin Brodszky; Zsuzsanna Végh; Silvio Danese; Peter M Irving; Laurent Peyrin-Biroulet; Stefan Schreiber; Fanni Rencz; Péter L Lakatos; Márta Péntek
Journal: United European Gastroenterol J Date: 2017-05-08 Impact factor: 4.623